Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 288

1.

Preferred muscles in cervical dystonia.

Jost WH, Biering-Sørensen B, Drużdż A, Kreisler A, Pandey S, Sławek J, Tatu L.

Neurol Neurochir Pol. 2020 Mar 30. doi: 10.5603/PJNNS.a2020.0022. [Epub ahead of print]

2.

Influence of levodopa on orthostatic hypotension in Parkinson's Disease.

Jost WH, Altmann C, Fiesel T, Becht B, Ringwald S, Hoppe T.

Neurol Neurochir Pol. 2020 Mar 27. doi: 10.5603/PJNNS.a2020.0019. [Epub ahead of print]

3.

What are the considerations for anti-hypertensive treatment in patients with Parkinson's disease?

Jost WH.

Expert Opin Pharmacother. 2020 Mar 20:1-4. doi: 10.1080/14656566.2020.1744565. [Epub ahead of print] No abstract available.

PMID:
32196396
4.

Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study.

Reichmann H, Lees A, Rocha JF, Magalhães D, Soares-da-Silva P; OPTIPARK investigators.

Transl Neurodegener. 2020 Mar 4;9:9. doi: 10.1186/s40035-020-00187-1. eCollection 2020.

5.

[Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language].

Klingelhoefer L, Jost W, Odin P, Storch A, Ray Chaudhuri K, Reichmann H.

Nervenarzt. 2020 Mar 6. doi: 10.1007/s00115-020-00885-1. [Epub ahead of print] German.

PMID:
32144450
6.

Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.

Schröter N, Blazhenets G, Frings L, Barkhausen C, Jost WH, Weiller C, Rijntjes M, Meyer PT.

Clin Nucl Med. 2020 Apr;45(4):283-287. doi: 10.1097/RLU.0000000000002949.

PMID:
32108694
7.

Selective lower body perfusion during aortic arch surgery in neonates and small children.

Boburg RS, Rosenberger P, Kling S, Jost W, Schlensak C, Magunia H.

Perfusion. 2020 Jan 21:267659119896890. doi: 10.1177/0267659119896890. [Epub ahead of print]

PMID:
31960747
8.

Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study.

Francisco GE, Jost WH, Bavikatte G, Bandari DS, Tang SFT, Munin MC, Largent J, Adams AM, Zuzek A, Esquenazi A.

PM R. 2020 Jan 17. doi: 10.1002/pmrj.12328. [Epub ahead of print]

PMID:
31953896
9.

The Progressive Supranuclear Palsy Clinical Deficits Scale.

Piot I, Schweyer K, Respondek G, Stamelou M; DescribePSP study group; ProPSP study group; MDS-endorsed PSP study group, Sckopke P, Schenk T, Goetz CG, Stebbins GT, Höglinger GU.

Mov Disord. 2020 Jan 17. doi: 10.1002/mds.27964. [Epub ahead of print]

PMID:
31951049
10.

Injection into the Longus Colli Muscle via the Thyroid Gland.

Tyślerowicz M, Jost WH.

Tremor Other Hyperkinet Mov (N Y). 2019 Dec 6;9. doi: 10.7916/tohm.v0.718. eCollection 2019.

11.

Frequency of different subtypes of cervical dystonia: a prospective multicenter study according to Col-Cap concept.

Jost WH, Tatu L, Pandey S, Sławek J, Drużdż A, Biering-Sørensen B, Altmann CF, Kreisler A.

J Neural Transm (Vienna). 2020 Jan;127(1):45-50. doi: 10.1007/s00702-019-02116-7. Epub 2019 Dec 11.

PMID:
31828512
12.

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Dorsch U, Csikós J, Blitzer A.

Parkinsonism Relat Disord. 2020 Jan;70:23-30. doi: 10.1016/j.parkreldis.2019.11.024. Epub 2019 Nov 26.

PMID:
31794936
13.

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients.

Cattaneo C, Jost WH, Bonizzoni E.

J Parkinsons Dis. 2020;10(1):89-97. doi: 10.3233/JPD-191765.

14.

Therapy of Sialorrhea with Botulinum Neurotoxin.

Jost WH, Bäumer T, Laskawi R, Slawek J, Spittau B, Steffen A, Winterholler M, Bavikatte G.

Neurol Ther. 2019 Dec;8(2):273-288. doi: 10.1007/s40120-019-00155-6. Epub 2019 Sep 21. Review.

15.

Torticaput versus Torticollis: Clinical Effects with Modified Classification and Muscle Selection.

Jost WH.

Tremor Other Hyperkinet Mov (N Y). 2019 Jul 12;9. doi: 10.7916/tohm.v0.647. eCollection 2019.

16.

[Therapy of sialorrhea with botulinum toxin].

Jost WH, Bäumer T, Laskawi R, Spittau B, Steffen A, Winterholler M.

Fortschr Neurol Psychiatr. 2019 Oct;87(10):554-563. doi: 10.1055/a-0958-2417. Epub 2019 Jul 25. German.

PMID:
31344747
17.

Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators.

Brumberg J, Blazhenets G, Schröter N, Frings L, Jost WH, Lapa C, Meyer PT.

EJNMMI Phys. 2019 Jul 23;6(1):12. doi: 10.1186/s40658-019-0250-2.

18.

The challenge of pain in the pharmacological management of Parkinson's disease.

Jost WH, Buhmann C.

Expert Opin Pharmacother. 2019 Oct;20(15):1847-1854. doi: 10.1080/14656566.2019.1639672. Epub 2019 Jul 10. Review.

PMID:
31290336
19.

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM.

J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. Review.

PMID:
31240402
20.

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L.

J Neural Transm (Vienna). 2019 Jul;126(7):879-888. doi: 10.1007/s00702-019-02034-8. Epub 2019 Jun 20.

PMID:
31222604

Supplemental Content

Loading ...
Support Center